跳至主要内容
临床试验/NCT06569940
NCT06569940招募中不适用

Single-center Evaluation of Sleepiz One+ Algorithm in Estimating Respiration Rate and Heart Rate Compared to Gold Standard

Sleepiz AG1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年7月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Sleepiz AG
入组人数
35
试验地点
1
主要终点
Instantaneous respiration rate measurement accuracy per 60s epoch

研究概览

简要总结

Respiratory Rate (RR) and heart rate (HR) are vital signs crucial for assessing a patient's overall health, providing insights into various conditions and stressors. Effective management of chronic diseases relies on detecting pathological changes early, with RR being among the most sensitive predictors of patient deterioration. Therefore, vigilant monitoring of RR and HR is vital for improving patient outcomes.

The primary aim of this study is to provide a thorough comparison of the performance of Sleepiz One+ algorithms and end-tidal carbon dioxide measurement (EtCO2) Capnography for measuring respiration rate and electrocardiography (ECG) for measuring heart rate, in healthy adults and patients suffering from chronic conditions (e.g., hypertension, Chronic Obstructive Pulmonary Disease (COPD), asthma, diabetes), at rest in a clinical setting when the data is acquired with the new hardware version. Additionally, the investigators will evaluate the performance of RR estimation against the thoracic effort belt and the HR against the pulse oximetry.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

盲法说明

Annotators of capnography data were blinded to the values provided by the investigational device

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age >=18years
  • •Informed Consent as documented by signature
  • •One (or more) chronic medical condition/s (e.g., diabetes, asthma, cardiovascular or respiratory diseases, etc.)
  • •Healthy volunteers
  • •Age >=18years
  • •Informed Consent as documented by signature
  • •No diagnosed chronic medical condition

排除标准

  • •Previous enrolment into the current study,
  • •Cardiac pacemaker or another implanted electrical device
  • •Women who are pregnant or breastfeeding
  • •Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, delirium etc. of the participant
  • •Healthy volunteers:
  • •Previous enrolment into the current study,
  • •Cardiac pacemaker or another implanted electrical device
  • •Women who are pregnant or breastfeeding
  • •Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, delirium etc. of the participant
  • •Presence of diagnosed chronic medical condition

研究组 & 干预措施

Sleepiz One+ vs. gold standard

Other

Each enrolled participant will undergo a simultaneous recording with the Sleepiz One+, Capnography device and cardiorespiratory polygraphy to measure respiration rate at and heart rate at rest, while sitting and lying down on a bed.

干预措施: Sleepiz One+ (Device)

结局指标

主要结局

Instantaneous respiration rate measurement accuracy per 60s epoch

时间窗: During 60 seconds

Instantaneous respiration rate measurement accuracy per 60s epoch against visually scored capnography data, recorded on subjects lying down and resting on a bed

Instantaneous heart rate measurement accuracy per 60s epoch

时间窗: During 60 seconds

Instantaneous heart rate measurement accuracy per 60s epoch against ECG R-R interval, recorded on subjects lying down and resting on a bed

次要结局

未报告次要终点

研究者

发起方
Sleepiz AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验